Published in Ter Arkh on January 01, 2014
Surgical treatment of the Wolff-Parkinson-White syndrome by epicardial electrical ablation. Ann Thorac Surg (1991) 1.40
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
[C-reactive protein--marker of inflammation in atherosclerosis (new data)]. Kardiologiia (2002) 0.88
[Investigation of mechanisms of neuro-protective effect of semax in acute period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.87
Structures of the apo and holo forms of formate dehydrogenase from the bacterium Moraxella sp. C-1: towards understanding the mechanism of the closure of the interdomain cleft. Acta Crystallogr D Biol Crystallogr (2009) 0.87
The structure of deoxy- and oxy-leghaemoglobin from lupin. J Mol Biol (1995) 0.84
[Neopterin: new immunological marker of autoimmune rheumatic disease]. Klin Med (Mosk) (2000) 0.83
Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Ann Rheum Dis (2006) 0.83
[Evaluation of methotrexate effect on the acute-phase response in rheumatoid arthritis after 12-week treatment]. Klin Med (Mosk) (2014) 0.82
The binding of carbon monoxide and nitric oxide to leghaemoglobin in comparison with other haemoglobins. J Mol Biol (1996) 0.82
[Anti-phosphatidylethanolamine antibodies in patients with Sneddon's syndrome]. Klin Med (Mosk) (2005) 0.82
[Synchronous and metachronous myeloid and lymphoid tumors]. Ter Arkh (2014) 0.82
[Changes in the indicators of bone marrow and blood based on the complex cytological examination of 28 children from the Bryansk region 1 year after the accident at the Chernobyl atomic power plant]. Gematol Transfuziol (1991) 0.82
[Expert system for the diagnosis of thyroid neoplasms]. Arkh Patol (2004) 0.82
[Cardiolipin antibodies in acute rheumatic fever]. Klin Med (Mosk) (1992) 0.82
[Ultrasound spatial clinical analysis of the orbital part of the lacrimal gland in health]. Vestn Oftalmol (2007) 0.82
[POEMS-syndrome: a literature review and case reports]. Zh Nevrol Psikhiatr Im S S Korsakova (2014) 0.81
[The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results]. Ter Arkh (2012) 0.81
[Malignant histiocytosis in children (pathologicoanatomic study of 16 cases)]. Arkh Patol (1983) 0.80
[Richter's syndrome: analysis of literature data and original observations]. Ter Arkh (1999) 0.80
C3a and C5a anaphylatoxins bind to heparin-based sorbent in low density lipoprotein apheresis: in vitro and in vivo investigations. Artif Organs (1992) 0.80
[Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions]. Ter Arkh (2009) 0.80
[Cardiolipin antibodies in patients with myocardial infarction and unstable angina pectoris]. Kardiologiia (1992) 0.80
[Cardiac rhythm and conduction disorders in polymyositis and dermatomyositis]. Klin Med (Mosk) (1998) 0.80
[DNA-hydrolyzing antibodies in lymphoproliferative disorders]. Biull Eksp Biol Med (1996) 0.80
[Tuberculosis of the lungs complicated by opisthorchiasis under conditions of the extreme north]. Probl Tuberk (1989) 0.79
[Sarcoidosis: etiology, pathogenesis, epidemiology, risk factors, clinical presentation]. Vestn Oftalmol (2012) 0.79
[Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease]. Ter Arkh (2004) 0.79
[Effect of small-dose glucocorticoids on the course of early rheumatic arthritis]. Klin Med (Mosk) (2004) 0.79
[Magnetophoresis and magnetic susceptibility of HeLa tumor cells]. Biofizika (2006) 0.79
[Serum neopterin in hepatitis B]. Klin Med (Mosk) (1992) 0.78
[Synovial membrane in the early stage of rheumatoid arthritis: clinico-morphological comparisons]. Ter Arkh (2003) 0.78
[Structum (chondroitin sulfate)--a new agent for the treatment of osteoarthrosis]. Ter Arkh (1999) 0.78
[New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)]. Ter Arkh (2010) 0.78
[Ocular surface system integrity]. Vestn Oftalmol (2015) 0.78
[Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial]. Ter Arkh (2005) 0.77
[The importance of cytokine profile characteristics for evaluating the therapeutic effectiveness of monoclonal antibodies against IL-6 receptors in patients with rheumatoid arthritis]. Klin Med (Mosk) (2014) 0.77
[Stomach MALT-lymphoma with marked plasmocytic differentiation: a variant of Mott's cell tumor]. Arkh Patol (2004) 0.77
[The magnitude of fatigue and its association with depression, pain, and inflammatory activity in rheumatoid arthritis]. Ter Arkh (2013) 0.77
[Serum nitrates in patients with systemic lupus erythematosus and antiphospholipid syndrome]. Ter Arkh (2004) 0.77
[Cardiovascular diseases in rheumatoid arthritis]. Ter Arkh (2007) 0.77
[Role of splenectomy in the treatment of myelofibrosis]. Ter Arkh (2013) 0.77
Chromosomal characteristics of malignant lymphoma. Hum Genet (1989) 0.77
[Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis]. Ter Arkh (2013) 0.77
[Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases]. Vestn Oftalmol (2002) 0.77
[The von Willebrand factor antigen in patients with rheumatoid arthritis: a method for its determination and the clinical significance]. Ter Arkh (1993) 0.77
[Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis]. Ter Arkh (2009) 0.77
[Prospects for the assessment of cardiac rhythm variability in patients with rheumatoid arthritis and systemic lupus erythematosus]. Vestn Ross Akad Med Nauk (2010) 0.77
[Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus]. Kardiologiia (2002) 0.77
[The hypophyseal-testicular system in cryptorchism patients following surgical treatment]. Probl Endokrinol (Mosk) (1990) 0.76
[Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome]. Klin Med (Mosk) (1998) 0.76
[X-ray diffraction and biochemical studies of W34F mutant ribonuclease binase]. Mol Biol (Mosk) (2010) 0.76
Anticardiolipin antibodies in Sneddon's syndrome. Neurology (1990) 0.76
Ultrastructural criteria of malignancy of adrenal medullary tumor. Bull Exp Biol Med (2002) 0.76
[Evaluation of the efficacy and tolerance of ibandronic acid in patients with osteoarthrosis in the knee joints concurrent with osteoporosis: a pilot study]. Ter Arkh (2013) 0.76
Use of human VEGF(165) gene for therapeutic angiogenesis in coronary patients: first results. Bull Exp Biol Med (2005) 0.76
[Soluble receptors of TNF-alpha with molecular mass 55 kDa in rheumatoid arthritis: clinical role]. Klin Med (Mosk) (2003) 0.76
[The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II]. Ter Arkh (1989) 0.76
[Autoantibodies Against beta(1)-Adrenoreceptors in Patients With Cardiac Rhythm Disorders. Prevalence and Possible Role in Development of Arrhythmia]. Kardiologiia (2004) 0.76
[Soluble adhesion molecules (P-selectin, ICAM-1 and ICAM-3) in rheumatoid arthritis]. Ter Arkh (1999) 0.76
[Cognitive impairment and anxiety-depressive disorders in patients with rheumatoid arthritis]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.76
Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol (1991) 0.76
[Markers of chronic inflammation in patients with ischemic heart disease with in-stent restenosis]. Kardiologiia (2005) 0.76
[The clinical significance of neopterin in human diseases]. Ter Arkh (1993) 0.76
[Soluble receptors of TNF-alpha in rheumatoid arthritis]. Klin Med (Mosk) (2001) 0.76
[Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome]. Ter Arkh (2008) 0.76
[Sneddon's syndrome and the primary antiphospholipid syndrome]. Ter Arkh (1993) 0.76
[Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome]. Ter Arkh (2006) 0.76
[Differential diagnosis of Wegener's granulomatosis and extranodal NK/T-cell lymphoma, nasal type]. Ter Arkh (2012) 0.76
[Prognistic value of a study of the expression of argyrophilic nucleolar organizer region associated proteins in case of papillary thyroid cancer]. Arkh Patol (2010) 0.76
[Pharmacotherapy of rheumatoid arthritis: the 21st century]. Klin Med (Mosk) (2005) 0.75
[Potentialities of confocal microscopy in the evaluation of the cornea in the dry eye syndrome]. Vestn Oftalmol (2009) 0.75
[The rate of HCV-RNA detection in the serum, saliva, and tissue of the minor salivary glands in chronic hepatitis C with Sjogren's syndrome]. Klin Med (Mosk) (2003) 0.75